Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Loxoprofen sodium hydrate gel for knee osteoarthritis pain
CTR20241651Phase 3Completed
- Sponsor
- Shanghai Yan'an Pharmaceutical
- Start
- May 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of loxoprofen in knee osteoarthritis (OA), sponsored by Shanghai Yan'an Pharmaceutical. Started May 2024; status: completed.
02
Drugs
loxoprofen
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on CTR20241651.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20241651.